Hidden Bibliographic Details
| Other authors / contributors: | Sharfman, William.
|
|---|
| ISBN: | 9781617051616
1617051616
9781936287796
|
|---|
| Notes: | Includes bibliographical references and index.
|
|---|
| Summary: | This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few years ago. Especially significant are the recent FDA approval of the immunotherapeutic agent ipilimumab for metastatic melanoma, and new agents targeting the BRAF gene in malignant melanoma. There is also coverage of the most recent data pertaining to surgical management, staging and prevention, an.
|
|---|
| Other form: | Print version: Sharfman, William. Melanoma. New York : Demos Medical Publishing, ©2012 9781936287796
|
|---|
